Houston, TXNCT05977998Now EnrollingIRB Ready

Gastric Adenocarcinoma Clinical Trial in Houston, TX

Access cutting-edge gastric adenocarcinoma treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by M.D. Anderson Cancer Center

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access gastric adenocarcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related gastric adenocarcinoma treatment provided free

Apply for This Houston Location

Check if you qualify for this gastric adenocarcinoma clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Gastric Adenocarcinoma Study in Houston

To learn about the effects of paclitaxel and gastrectomy (surgery to remove all or part of the stomach) on improving outcomes in patients with gastric cancer.

Sponsor: M.D. Anderson Cancer Center

Who Can Participate

Inclusion Criteria

Age 18 years and above. There will be no upper age restriction. Because no dosing or adverse event data are currently available on the use of intraperitoneal paclitaxel in patients \<18 years of age, children are excluded from this study.
ECOG performance status ≤ 2 (Karnofsky ≥60%). Appendices 1 and 2.
Cytologic or histologic proof of adenocarcinoma of the stomach or gastroesophageal junction.
Adequate renal, and bone marrow function:
Leukocytes \>= 3,000/uL
Absolute neutrophil count \>= 1,500/uL
Platelets \>= 60,000/Ul
Serum creatinine \<= 1.6 mg/dL
Distant Metastatic Disease of peritoneum:
Positive peritoneal cytology, or
Carcinomatosis on diagnostic laparoscopy or laparotomy.
Completion of preoperative systemic cytotoxic chemotherapy. Targeted therapy, such as HER2 directed therapy, and immunotherapy, such as PD-1 inhibitors, may be continued.
English and non-English speaking patients are eligible.

Exclusion Criteria

Distant metastatic disease not limited to the peritoneum such as solid organ metastases to the liver, central nervous system, or lung.
Infections such as pneumonia or wound infections that would preclude protocol therapy.
Women with a positive urine or serum pregnancy test are excluded from this study; women of childbearing potential (defined as those who are not postmenopausal defined as no menses in greater than or equal to 12 months, have not had a hysterectomy or bilateral salpingo-oophorectomy, do not have ovarian failure, or have not had a surgical sterilization procedure) must agree to refrain from breast-feeding and practice adequate contraception as specified in the informed consent. Adequate contraception consists of oral contraceptive, implantable contraceptives, injectable contraceptives, a double barrier method, or abstinence. Men with reproductive potential must agree to an appropriate method of birth control, including abstinence or double barrier method (diaphragm plus condom).
Subjects with unstable angina or New York Heart Association Grade II or greater congestive heart failure.
Subjects, such as those with cognitive impairment, deemed unable to comply with study and/or follow-up procedures.
Subjects with a known hypersensitivity to protocol systemic chemotherapy that was life-threatening, required hospitalization or prolongation of existing hospitalization, or resulted in persistent or significant disability or incapacity.
Previous surgery that would preclude safe cytoreduction and intraperitoneal port placement.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT05977998) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Gastric Adenocarcinoma Treatment Options in Houston, TX

If you're searching for gastric adenocarcinoma treatment options in Houston, TX, this clinical trial (NCT05977998) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gastric adenocarcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all gastric adenocarcinoma clinical trials near you to find additional studies recruiting in your area.

More Stomach Cancer Trials in Houston, TX

See all stomach cancer clinical trials recruiting in Houston — not just this study.

Browse Stomach Cancer Trials in Houston →

Browse More Trials by Condition

Stomach Cancer TrialsAlzheimers Disease TrialsAnkylosing Spondylitis TrialsAtopic Dermatitis TrialsInterstitial Cystitis TrialsGeographic Atrophy TrialsAll Conditions →

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX